NCT00829621View on ClinicalTrials.gov

Incisional Vacuum Assisted Closure (IVAC) Device and Its Effect on Implanted Bone Morphogenic Protein (BMP-2)

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

May 31, 2012

Study Completion Date

December 31, 2013

Conditions
Fractures, Closed
Interventions
OTHER

75 mmHg suction

Incisional Vacuum Assisted Closure (IVAC) Device, set to 75 mmHg suction throughout the duration of the IVAC use.

OTHER

125 mmHg

Incisional Vacuum Assisted Closure (IVAC) Device, set to 125 mmHg suction throughout the duration of the IVAC use.

Trial Locations (1)

65212

University of Missouri, Columbia

Sponsors

Collaborators (1)

Medtronic
All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

University of Missouri-Columbia

OTHER